Literature DB >> 33733391

Use of Ussing Chambers to Measure Paracellular Permeability to Macromolecules in Mouse Intestine.

Doriane Aguanno1,2, Bárbara Graziela Postal1,3,4, Véronique Carrière1,5, Sophie Thenet6,7,8.   

Abstract

An increased intestinal permeability has been described in many diseases including inflammatory bowel disease and metabolic disorders, and a better understanding of the contribution of intestinal barrier impairment to pathogenesis is needed. In recent years, attention has been paid to the leak pathway, which is the route of paracellular transport allowing the diffusion of macromolecules through the tight junctions of the intestinal epithelial lining. While the passage of macromolecules by this pathway is very restricted under physiological conditions, its amplification is thought to promote an excessive immune activation in the intestinal mucosa. The Ussing chambers have been widely used to measure both active and passive transepithelial fluxes in intact tissues. In this chapter we present how this simple device can be used to measure paracellular permeability to macromolecules in the mouse intestine. We propose a detailed protocol and describe how to best exploit all the possibilities of this technique, correctly interpret the results, and avoid the main pitfalls.

Entities:  

Keywords:  FITC-dextran; Intestinal permeability; Leak pathway; Mouse intestine; Ussing chambers

Mesh:

Substances:

Year:  2021        PMID: 33733391     DOI: 10.1007/7651_2021_367

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 2.  A guide to Ussing chamber studies of mouse intestine.

Authors:  Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

Review 3.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

4.  Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease.

Authors:  Constance S V Petit; Frédérick Barreau; Laura Besnier; Pierre Gandille; Béatrice Riveau; Danielle Chateau; Maryline Roy; Dominique Berrebi; Magali Svrcek; Philippe Cardot; Monique Rousset; Caroline Clair; Sophie Thenet
Journal:  Gastroenterology       Date:  2012-03-22       Impact factor: 22.682

Review 5.  Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease.

Authors:  Aaron Buckley; Jerrold R Turner
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

Review 6.  Tight junction, selective permeability, and related diseases.

Authors:  Susanne M Krug; Jörg D Schulzke; Michael Fromm
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 7.  Beyond Ussing's chambers: contemporary thoughts on integration of transepithelial transport.

Authors:  Jeremy R Herrmann; Jerrold R Turner
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-23       Impact factor: 4.249

Review 8.  The intestinal microbiota fuelling metabolic inflammation.

Authors:  Herbert Tilg; Niv Zmora; Timon E Adolph; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2019-08-06       Impact factor: 53.106

Review 9.  Human Intestinal Barrier Function in Health and Disease.

Authors:  Julia König; Jerry Wells; Patrice D Cani; Clara L García-Ródenas; Tom MacDonald; Annick Mercenier; Jacqueline Whyte; Freddy Troost; Robert-Jan Brummer
Journal:  Clin Transl Gastroenterol       Date:  2016-10-20       Impact factor: 4.488

10.  The Ussing chamber system for measuring intestinal permeability in health and disease.

Authors:  Amanda Thomson; Kathryn Smart; Michelle S Somerville; Sarah N Lauder; Gautham Appanna; James Horwood; Lawrence Sunder Raj; Brijesh Srivastava; Dharmaraj Durai; Martin J Scurr; Åsa V Keita; Awen M Gallimore; Andrew Godkin
Journal:  BMC Gastroenterol       Date:  2019-06-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.